Insights into the biology of HIV-1 viral protein R

被引:25
作者
Sherman, MP
De Noronha, CMC
Willliams, SA
Greene, WC
机构
[1] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94141 USA
[3] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94141 USA
关键词
D O I
10.1089/104454902760330228
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
HIV-1 viral protein R (Vpr) is a small, highly conserved accessory protein encoded by the HIV genome that serves many functions in the viral life cycle. Vpr induces G2 cell cycle arrest, which is thought to indirectly enhance viral replication by increasing transcription from the LTR. Vpr has also been implicated in facilitating infection of nondividing cells, most notably macrophages. Because Vpr is a nucleo-cytoplasmic shuttling protein, its role in enhancing viral replication in macrophages may be mediated through enhanced entry of the HIV preintegration complex through the limiting nuclear pore. Free Vpr is detectable in the serum of patients, and in vitro studies implicate extracellular forms of Vpr as an effector of cellular responses mediated through its ability to transduce through intact cytoplasmic membranes. We review the biologic properties of Vpr, focusing on its mechanism of action, role in HIV replication, and significance for host pathogenesis.
引用
收藏
页码:679 / 688
页数:10
相关论文
共 105 条
[1]   Vpr is preferentially targeted by CTL during HIV-1 infection [J].
Altfeld, M ;
Addo, MM ;
Eldridge, RL ;
Yu, XG ;
Thomas, S ;
Khatri, A ;
Strick, D ;
Phillips, MN ;
Cohen, GB ;
Islam, SA ;
Kalams, SA ;
Brander, C ;
Goulder, PJR ;
Rosenberg, ES ;
Walker, BD .
JOURNAL OF IMMUNOLOGY, 2001, 167 (05) :2743-2752
[2]   TUMOR-CELL RETENTION OF ANTIBODY FAB FRAGMENTS IS ENHANCED BY AN ATTACHED HIV TAT PROTEIN-DERIVED PEPTIDE [J].
ANDERSON, DC ;
NICHOLS, E ;
MANGER, R ;
WOODLE, D ;
BARRY, M ;
FRITZBERG, AR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 194 (02) :876-884
[3]   HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B [J].
Ayyavoo, V ;
Mahboubi, A ;
Mahalingam, S ;
Ramalingam, R ;
Kudchodkar, S ;
Williams, WV ;
Green, DR ;
Weiner, DB .
NATURE MEDICINE, 1997, 3 (10) :1117-1123
[4]   Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells? [J].
Azad, AA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 267 (03) :677-685
[5]   Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].
Berger, EA ;
Murphy, PM ;
Farber, JM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700
[6]   In vivo HIV-1 infection of CD45RA+CD4+ T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4+ T cell decline [J].
Blaak, H ;
van't Wout, AB ;
Brouwer, M ;
Hooibrink, B ;
Hovenkamp, E ;
Schuitemaker, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (03) :1269-1274
[7]   NUCLEAR TRANSLOCATION OF AN EXOGENOUS FUSION PROTEIN CONTAINING HIV TAT REQUIRES UNFOLDING [J].
BONIFACI, N ;
SITIA, R ;
RUBARTELLI, A .
AIDS, 1995, 9 (09) :995-1000
[8]   Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme [J].
Bouhamdan, M ;
Benichou, S ;
Rey, F ;
Navarro, JM ;
Agostini, I ;
Spire, B ;
Camonis, J ;
Slupphaug, G ;
Vigne, R ;
Benarous, R ;
Sire, J .
JOURNAL OF VIROLOGY, 1996, 70 (02) :697-704
[9]   HIV-1 infection requires a functional integrase NLS [J].
Bouyac-Bertoia, M ;
Dvorin, JD ;
Fouchier, RAM ;
Jenkins, Y ;
Meyer, BE ;
Wu, LI ;
Emerman, M ;
Malim, MH .
MOLECULAR CELL, 2001, 7 (05) :1025-1035
[10]   ACTIVE NUCLEAR IMPORT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PREINTEGRATION COMPLEXES [J].
BUKRINSKY, MI ;
SHAROVA, N ;
DEMPSEY, MP ;
STANWICK, TL ;
BUKRINSKAYA, AG ;
HAGGERTY, S ;
STEVENSON, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (14) :6580-6584